TAT Technologies Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $178M+17.0% YoYTTM through 31 Dec 2025
Net Income $16.8M+50.6% YoYTTM through 31 Dec 2025
Free Cash Flow $4MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 24.4% |
| EBITDA Margin | 13.4% |
| Operating Margin | 7.3% |
| Net Margin | 9.5% |
Returns
11.1%ROE
7.1%ROA
12.3%ROIC
Balance Sheet Health
Debt / Equity0.06x
Current Ratio4.54x
Net Debt-$40Mnet cash position
Cash & Equivalents$51.3M
Quality Metrics
Altman Z-Score7.91
Piotroski F-Score7 / 9
FCF Margin2.3%
Rule of 4012.7
Earnings-Beat Rate0.0%
Multi-Year Trend
RevenueFY2025: $178M
Diluted EPS$1.37TTMFY2025: $1.37
Dividend
$0.34Per share, FY20170.00%Yield
Capital Allocation
R&D Spend$1.4M
Capex Intensity6.2%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.